 |
MOSINTER GROUP LIMITED
lenvatinib Mesylate CAS 857890-39-2 E7080 Mesylate, China lenvatinib Mesylate CAS 857890-39-2 E7080 Mesylate Manufacturer
|
| Model: | MOS 23 |
| Place of Origin: | Zhejiang,China (Mainland) |
| Name: | lenvatinib Mesylate |
| CAS: | 857890-39-2 |
| Molecular Formula: | C21H19ClN4O4.CH4O3S |
| Brand: | MOSINTER |
| Content: | 98%min |
| Product Categories: | API |
| Synonyms 2: | E7080 Mesylate |
| Payment & Shipping Terms | Supply Capacity | ||
|---|---|---|---|
| Payment Terms: | L/C, T/T, WU | Production Capacity: | 200KG/MONTH |
| Min. Order: | 1 Kilogram | Packing: | As per request of... |
| Means of Transport: | Ocean, Air, Land | Delivery Date: | within 7 days |
lenvatinib Mesylate CAS 857890-39-2 E7080 Mesylate
Lenvatinib (trade name Lenvima) is an anti-cancer drug for the treatment of certain kinds of thyroid cancer, and potentially for other cancers as well.
Usage | E7080 (Lenvatinib) is a multi-target inhibitor of VEGFR2 and VEGFR3 with IC50 of 4 nM and 5.2 nM, respectively. |
Definition | ChEBI: A methanesulfonate salt obtained by reaction of lenvatinib with one molar equivalent of methanesulfonic acid. A multi-kinase inhibitor and orphan drug used (as its mesylate salt) for the treatment of various types of thyroid cancer that do not respond to r dioiodine. |
PACKING 
PACKING
Category: Antineoplastic Drugs API
Related Category: Other Pharmaceutical API Veterinary Medicine API Diagnostic Agents API Vitamin Preparation API Psychotropic Drugs API
